Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Hepatol. Jun 27, 2025; 17(6): 108100
Published online Jun 27, 2025. doi: 10.4254/wjh.v17.i6.108100
Table 2 Outcomes between short-course and long-course antimicrobial treatment groups, n (%)
Outcomes
Short-course treatment (< 14 days) (n = 19)
Long-course treatment (≥ 14 days) (n = 25)
P value
30-day mortality0 (0)0 (0)
Recurrence of cholangitis within 3 months1.000
Yes1 (5.3)2 (8.0)
No18 (94.7)23 (92.0)
Reinfection with the same organism within 3 months0 (0)0 (0)
Length of hospital stay (median, interquartile range)12.0 (7.5-13.0)14.0 (9.0-18.0)0.092